Figure 2.

Phenotypic characterization of CD7⁺CD56⁺CD16⁺ and CD7⁺CD56^negCD16⁺ NK cells and CD7^negCD56^negCD16⁺ cells in healthy donors. CD3^negCD14^negCD19^neg cells were gated for CD56⁺ and CD56^neg cells and plotted against CD7 to identify CD7⁺ NK cells and CD7^neg monocyte or DC-like cells. The percentage of CD7⁺CD56⁺CD16⁺ and CD7⁺CD56^negCD16⁺ NK cells and CD7^negCD56^negCD16⁺ monocyte or DC-like cells expressing each receptor was determined (n = 6). A-I, Expression of NK cell-associated receptors on the different cell subsets. J-M, Expression of myeloid-associated markers on the different cell subsets. The median and 25th and 75th percentile are indicated on each graph.